Consio | $3,300,000 | (Jan 27, 2026)
Orbital(US) | $60,000,000 | (Jan 27, 2026)
Inferact | $150,000,000 | (Jan 27, 2026)
BioSqueeze Inc.
United States
- Butte, Montana
- 23/02/2023
- Series A
- $7,400,000
BioSqueeze Inc. headquartered in Butte, Montana is the world leader in commercial biomineralization. BioSqueeze® is an innovative, fluid-based biotechnology that seals miniscule leakage pathways in oil and gas wells. BioSqueeze forms a crystalline calcium carbonate barrier similar to limestone that permanently eliminates sustained casing pressure (SCP) and prevents fugitive greenhouse gas emissions (GHG).
Through continued innovation we are constantly seeking to develop and deploy additional biomineralization applications with new technology including enhanced oil recovery, sand control, and soil stabilization.
- Industry Oil and Gas
- Website https://biosqueeze.com/
- LinkedIn https://www.linkedin.com/company/biosqueeze/
Related People
Mark RanalliFounder
United States -
Bozeman, Montana
A forward-thinking and analytical executive business leader, possessing a combination of both strategic vision and operational leadership. Experienced at building and leading teams, sales and marketing, strategic planning, mergers and acquisitions, branding, business development, and product development. Possess a proven track record of success in founding and driving innovative businesses. Experienced at raising capital through private equity, strategic partnerships, and public markets.
Visitt | $22,000,000 | (Jan 27, 2026)
Cashmere(US) | $5,000,000 | (Jan 27, 2026)
Barnwell Bio | $6,000,000 | (Jan 27, 2026)
Mine(US) | $14,000,000 | (Jan 27, 2026)
Lucend | $3,300,000 | (Jan 27, 2026)
Standard Nuclear | $140,000,000 | (Jan 27, 2026)
Yuki | $6,000,000 | (Jan 23, 2026)
Allocation Strategy | $2,164,392 | (Jan 23, 2026)
Mia Labs | $20,000,000 | (Jan 23, 2026)